Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03586024 between the old and new screenshots. Core elements such as eligibility criteria, study design, and key sections remain unchanged.
    Difference
    0.5%
    Check dated 2025-10-27T20:59:53.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T07:57:29.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Update: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:22:05.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Version updated to v3.0.2; older v3.0.1 tag and the Back to Top element were removed.
    Difference
    0.3%
    Check dated 2025-09-14T22:09:56.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T19:16:57.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new content related to Hemic and Lymphatic Diseases and pembrolizumab. However, many specific disease-related terms and previous location details have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:29:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.